Articles & releases

BB Pureos Bioventures in the press

Publication Date Article (Link)
European Biotechnology April 2019 Alentis Therapeutics debuts with CHF 12.5 mn
Basellaunch April 2019 Alentis raises 12.5 million Swiss francs
transkript.de April 2019 Alentis Therapeutics AG startet mit 12.5 Mio. CHF-Runde
Labiotech.eu April 2019 Swiss biotech raises EUR 11 mn to develop treatments fo liver fibrosis
Biocentury.com April 2019 Why liver disease newco Alentis is aiming for one of largest Swiss A rounds
Scrip  April 2019 Liver disease newco Alentis raises CHF 12.5 mn Series A
FierceBiotech April 2019 Alentis raises series A round to advance drug against novel liver disease target
Endpoints News April 2019 A biotech fledgling cross-bred in France and Switzerland launches to take on liver problems of global dimensions
Finews.ch September 2018 Klaus Breiner: 7 Myths about biotech risk capital
Media release June 2018 Hochkarätiger Beirat für neue Risikokapitalgesellschaft BB Pureos Bioventures
SRF ECO June 2018 Gründer-Schwerpunk mit Fokus auf den Faktor Mensch
NZZ.ch May 2018 Fünf Fragen an Dominik Escher
NZZ.ch April 2018 Im Biotech-Sektor klafft eine Finanzierungslücke
Handelszeitung.ch February 2018 Bellevue Group setzt mit neuem Fonds auf Biotech
startupticker.ch February 2018 Bellevue Asset Management gründet neue Risikokapitalgesellschaft
Finews February 2018 Bellevue bids for more risk capital
SRF ECO February 2018 Pharma-Zwerge: Lukrative Innovation
NZZ February 2018 Zweierlei Investorenverhalten in der Biotech-Industrie
Agéfi February 2018 Pureos Bioventures se focalise sur les biotechs actives dans la recherche de médicaments
Media release  February 2018 Initative for venture capital in Switzerland